Approximately 40-50% of SLE patients are positive for anti-TRIM21 antibodies, frequently combined with anti-Ro60 and anti-La antibodies; the occurrence of anti-TRIM21 antibody positivity by itself is uncommon in SLE, Table 3 (141, 146, 147). This evidence concerns the gene SSB and systemic lupus erythematosus.